Rate cuts have finally arrived, and certain stocks stand to gain from the shift in monetary regime. Click here to learn more ...

Zimmer Biomet faces challenges amid uncertainties and recalled product, leading to potential downside risks and a volatile ...

As we can see, the Western Asset Investment Grade Income Fund currently has a yield that is rather unattractive when compared ...

The John Hancock Preferred Income Fund offers an 8.04% yield, but it trades at an 8.84% premium to NAV. Click here to read an ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

Steelcase Inc. stock dropped despite strong earnings, why it remains a good buy, and management's outlook. Read more on SCS ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Smartsheet (SMAR) stock drops 1.3% as COO leaves amid reports of potential $8 billion acquisition by Vista Equity and ...

Lululemon has had recent product stumbles, indicating they may be losing their edge. See why I feel LULU stock is undervalued ...

White Mountains has a long-term track record of solid performance through market cycles, with 14% CAGR and strong ROEs. Read ...

The economy is good, but not great. But inflation expectations among younger and lower-income people are high. The ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...